new asthma drug, Accolate (zafirlukast)
November 1996
Zeneca is hoping to make a big splash with their new asthma drug, Accolate (zafirlukast).
It's the first drug in a new class...leukotriene receptor antagonists (LTRA). Leukotrienes have been a HUGE area for asthma research...their discovery resulted in a Nobel prize.
Leukotrienes are pro-inflammatory substances. They're released when mast cells are exposed to allergens. In the lung, leukotrienes trigger bronchoconstriction...inflammation...and edema.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote